Clinicopathologic Conference, Infant Botulism, Case 3-2024
NEJM 390:358-366, Case 3-2024, 2024
Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023
Clinical Radiologic Features of Encephalopathy during 2011 E Coli O111 outbreak in Japan
Neurol 82:564-572, Takanashi, J.,et al, 2014
Toxic Leukoencephalopathy
NEJM 345:425-432, Filley,C.M. &Kleinschmidt-DeMasters,B.K., 2001
Cisplatin Neurotoxicity Presenting as Reversible Posterior Leukoencephalopathy Syndrome
AJNR 19:415-417, 5911998., Ito,Y.,et al, 1998
Cortical Hyperintensity on Proton Density-Weighted Images:An MR Sign of Cyclosporine-Related Encephalopathy
AJNR 17:337-344, Jansen,O.,et al, 1996
Transient Ara-C Leukoencephalopathy:MR Findings
J Comput Assist Tomogr 20:161-169, Patel,A.G.&Rao,R., 1996
Transient Encephalopathy after Paclitaxel (Taxol) Infusion
Neurol 46:1596-1599, Perry,J.R.&Warner,E., 1996
Acute Neuromuscular Respiratory Paralysis
JNNP 56:334-343, Hughes,R.A.C.&Bihari,D., 1993
Dangers from Methylprednisolone Acetate Therapy by Intraspinal Injection
Arch Neurol 45:804-806, Nelson,D.A., 1988
Neurotoxicity of Commonly Used Antineoplastic Agents
NEJM 291:75, 1271974., Weiss,H.,et al, 1974